Explore
Validate
LearnABIN951300
antibody from antibodies-online
Targeting: FGFR1
BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951300 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fibroblast Growth Factor Receptor 1 (FGFR1) (Tyr307) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Tyr307
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
The transition from radial glial to intermediate progenitor cell is inhibited by FGF signaling during corticogenesis.
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Turner N, Pearson A, Sharpe R, Lambros M, Geyer F, Lopez-Garcia MA, Natrajan R, Marchio C, Iorns E, Mackay A, Gillett C, Grigoriadis A, Tutt A, Reis-Filho JS, Ashworth A
Cancer research 2010 Mar 1;70(5):2085-94
Cancer research 2010 Mar 1;70(5):2085-94
Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
Chen G, Tian X, Liu Z, Zhou S, Schmidt B, Henne-Bruns D, Bachem M, Kornmann M
British journal of cancer 2010 Jan 5;102(1):188-95
British journal of cancer 2010 Jan 5;102(1):188-95
The transition from radial glial to intermediate progenitor cell is inhibited by FGF signaling during corticogenesis.
Kang W, Wong LC, Shi SH, Hébert JM
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009 Nov 18;29(46):14571-80
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009 Nov 18;29(46):14571-80
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.
Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
International journal of immunopathology and pharmacology 2009 Jul-Sep;22(3):627-38
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
